AI-powered rare disease intelligence

Transforming genomic, clinical, and population data into insights that improve outcomes, advance equity, and reduce the cost and capacity strain of late-stage disease.

With advanced AI and global health data, we can

SEE

the hidden drivers of late-stage progression that health systems miss

FORECAST

recurrence, progression, and high-burden events before they overwhelm patients and services

DELIVER

actionable insights to health systems, payers, and clinicians — without disrupting workflows

CHANGE

the future of rare disease care by closing equity gaps, improving survival, and reducing avoidable late-stage costs

Our Technology

AnnieGuard is building a rare disease intelligence platform designed to detect aggressive biology earlier, improve survival, and relieve system burden.

Thousands

of de-identified health records analyzed across genomic, clinical, and population data streams

7-day turnaround

from secure dataset to actionable, population-level insights

Improved survival

through earlier detection of hidden progression risk

System relief

by reducing avoidable late-stage cases that drive the highest burden of oncology care

Validated evidence

aligned with NHS early detection goals and U.S. value-based care models

Seamless deployment

no workflow disruption, compliant with HIPAA, GDPR, and NHS DSPT

Scalable platform

sarcoma first, with expansion into other rare diseases

This is AI-powered rare disease intelligence.

This is the future of proactive, equitable healthcare.

Contact